Docetaxel for Castration-sensitive Prostate Cancer: Wrapping up Unfinished Business? [electronic resource]
- European urology Apr 2016
- 574-575 p. digital
Publication Type: Editorial; Comment
1873-7560
10.1016/j.eururo.2015.10.022 doi
Antineoplastic Agents--therapeutic use Humans Male Orchiectomy Prostatic Neoplasms--drug therapy Prostatic Neoplasms, Castration-Resistant--drug therapy